Medtronic Plc recently announced the receipt of 510 k clearance from the FDA for its Accurian RF ablation platform. This clearance will help the company with its strategy to strengthen position in the huge chronic pain management market.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category Health